Mabtas RA 500mg Inj

About Mabtas RA 500mg Inj

Mabtas RA 500mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.Mabtas RA 500mg Injection is given as an injection under the supervision of doctor. You must take it in a dose as advised by the doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.The most common side effects of this medicine include headache, weakness, edema, infection, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with hepatitis B.Before taking it, tell your doctor if you have heart disease, liver, or planning surgery or vaccination or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. 

Targeted Therapy for Complex Conditions

Mabtas RA 500mg Injection is designed to deliver effective treatment for adults suffering from Rheumatoid Arthritis, Non-Hodgkin's Lymphoma, and Chronic Lymphocytic Leukemia. Its active ingredient, rituximab, targets specific immune cells, helping to ease symptoms and slow disease progression. Administered in a hospital setting, it is used in conjunction with other treatments under the close supervision of healthcare professionals.


Administration and Handling

This medication is available as a single-use vial containing a clear, colorless solution, and is administered only via intravenous infusion by qualified medical staff. Dosage is determined and managed by physicians to ensure safety and effectiveness. It is not intended for self-administration, and strict storage conditions between 2C and 8C must be maintained to preserve efficacy.


Safety and Precautions

Mabtas RA 500mg must be prescribed by a healthcare provider and is accompanied by a risk of potential side effects such as infusion-related reactions, low blood cell counts, and infections. All administrations are monitored for safety, and patients are advised to promptly report any unusual symptoms. The medication must not be frozen and should always be handled by professional healthcare providers only.